INDIGO Press Releases
Catch up on the latest news and announcements from INDIGO Biosciences.
New Assay Cell-Based Luciferase Reporter Assay developed for GM-CSFR
INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR.State College, PA (June 27th, 2023) – Today INDIGO Biosciences announced the release of a new cell-based reporter assay for Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR or CSF2R). This new commercially available all-inclusive assay kit from INDIGO can help preclinical researchers get the data they…
New Environmental Monitoring and Toxicology Assays
INDIGO’s New Family of Assays for Environmental Monitoring and Toxicology Provide a Screening Tool for Endocrine Disrupting Chemicals.State College, PA (May 18, 2023) – Today INDIGO Biosciences released a new family of cell-based luciferase reporter assays specifically developed for use in environmental testing applications such as screening samples for endocrine disrupting chemicals. The assays include…
INDIGO Biosciences Releases Reporter Assays for Insulin Receptor and Insulin-like Growth Factor 1 Receptor
Two New Assays for Preclinical Research of Cancer, Diabetes, and Cardiovascular DiseaseState College, PA (17 April 2023) – INDIGO Biosciences announced today the release of two new cell-based reporter assays for the Insulin Receptor, isoform B (INSRb) and Insulin-like Growth Factor 1 Receptor (IGF-1R), both members of the receptor tyrosine kinase (RTK) family.”These receptors are…
INDIGO Biosciences Announces Record Year for 2022
Cell-Based Assay Solutions Provider Books Another Year of Record GrowthState College, PA (February 22, 2023) – INDIGO Biosciences, Inc. (INDIGO), best known for its portfolio of cell-based luciferase reporter assays, experienced a record year of growth in 2022, with annual revenue 22% percent higher than 2021.”INDIGO provides exceptional value to the industries we serve,” said…
Human Tropomyosin Receptor Kinase TrkA, TrkB, TrkC Assays Now Available
Assays for Human Tropomyosin Receptor Kinases Developed to Help Identify Inhibitors and Activators of Nerve Growth Factor Receptors.State College, PA (January 3, 2023) – INDIGO Biosciences announced today the release of three new cell-based luciferase reporter assays for Human Tropomyosin Receptor Kinases TrkA (NTRK1), TrkB (NTRK2), and TrkC (NTRK3).TrkA, TrkB, and TrkC-also known as Neurotrophic…
TGR5 (GPBAR1) Assay for Human G Protein-Coupled Bile Acid Receptor 1 Now Available
TGR5 Assay Offers Insight for Drug Discovery Related to Diabetes, Cholesterol Management, and ObesityState College, PA (November 29, 2022) – Today INDIGO Biosciences announced the release of a new cell-based luciferase reporter assay for the Human G Protein-Coupled Bile Acid Receptor 1 (GPBAR1; TGR5).TGR5 is a bile acid membrane receptor of the GPCR family and…
INDIGO Biosciences Receives Approval from California Water Boards for Use of Its Bioassays in Recycled Water Monitoring
INDIGO’s Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor Alpha (ERα) Bioassays Approved for Monitoring Constituents of Emerging Concern Per Recycled Water PolicyState College, PA (November 7, 2022) – INDIGO Biosciences, Inc. has received approval from the California Water Boards, State Water Resources Control Board, for the use of two of its bioassays in recycled water…
INDIGO Biosciences Releases Assay for Human Tumor Protein P53
Cell-Based P53 Reporter Assay Provides Insight for Pre-Clinical Cancer Drug DiscoveryState College, PA (September 27, 2022) – INDIGO Biosciences announced today the addition of a new cell-based luciferase reporter assay for Human Tumor Protein P53. The new assay is part of INDIGO’s portfolio of assays for cancer research. The bioscience company’s cell-based luciferase reporter assays…
New Activator Protein 1 (AP-1) Assay from INDIGO Biosciences
Activator Protein 1 (AP-1) Assay Provides Researchers with Insight into Cancer and InflammationState College, PA (August 29, 2022) – INDIGO Biosciences announced today the addition of a new cell-based firefly luciferase reporter assay for the Human Activator Protein 1 (AP-1) transcription factor. The new assay augments INDIGO’s existing collection of related transcription factor assays including…
INDIGO Biosciences Develops Two New Progesterone Receptor Ortholog Assays
Rabbit PGR and Cynomolgus Monkey PGR Assays Grow INDIGO’s Ortholog Assays to Over FortyState College, PA (11 July 2022) – INDIGO Biosciences announced today the expansion of its portfolio of ortholog assays with two new progesterone receptor assays. INDIGO’s newest offerings include reporter assay systems for Cynomolgus Monkey Progesterone Receptor (NR3C3, PGR, PR) and Rabbit…